US Patent RE47885 Use of cannabidiol prodrugs in pharmaceutical compositions
Patent RE47885 was granted and assigned to Zynerba Pharmaceuticals on March, 2020 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
December 13, 2018
Date of Patent
March 3, 2020
Patent Applicant
Patent Application Number
16219285
Patent Inventor Names
Miroslaw Jerzy Golinski
0
Audra Lynn Strinchcomb
0
Dana Carmel Hammel
0
Jeffrey Lynn Howard
0
Stan Lee Banks
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent RE47885 Use of cannabidiol prodrugs in pharmaceutical compositions
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
